Iktos
AI for new drug design.
Overview
Iktos has developed a proprietary AI technology platform for in silico drug design. Their platform uses deep generative models to design novel molecules with desired properties, accelerating the hit-to-lead and lead optimization phases of drug discovery. They offer their technology as both a SaaS platform and through research collaborations.
✨ Key Features
- Makya™ generative AI SaaS platform
- Spaya™ synthesis planning software
- De novo drug design
- Multi-parametric optimization
- Retrosynthesis analysis
🎯 Key Differentiators
- Strong focus on generative models for de novo design.
- Integration of AI for design with retrosynthesis analysis.
- Flexible business model with both SaaS and collaboration options.
Unique Value: Accelerates the design of novel and optimized drug candidates through its generative AI platform.
🎯 Use Cases (4)
✅ Best For
- Has engaged in over 50 collaborations with pharmaceutical and biotech companies.
💡 Check With Vendor
Verify these considerations match your specific requirements:
- NA
🏆 Alternatives
Offers a strong focus on the creative and generative aspects of medicinal chemistry, going beyond screening to design new molecules from scratch.
💻 Platforms
🔌 Integrations
🛟 Support Options
- ✓ Email Support
- ✓ Dedicated Support (Enterprise tier)
💰 Pricing
✓ 14-day free trial
Free tier: NA
🔄 Similar Tools in AI for Drug Discovery
Atomwise
Utilizes deep learning for structure-based drug discovery to find small molecule hits....
Insilico Medicine
An end-to-end AI-driven drug discovery platform covering target identification, molecule generation,...
Recursion Pharmaceuticals
Industrializes drug discovery by combining automated biology with artificial intelligence....
Schrödinger
Provides a physics-based software platform for molecular discovery and design....
Valo Health
A technology company using human-centric data and AI to transform drug discovery and development....
BenevolentAI
Applies AI and machine learning to analyze biomedical information and accelerate drug discovery....